We are live on ! Find out more
SIG

Sargent Investment Group Portfolio holdings

AUM $759M
1-Year Est. Return 28.58%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+28.58%
3 Year Est. Return
+104.74%
5 Year Est. Return
+107.13%
10 Year Est. Return
–
AUM
$421M
AUM Growth
+$41.7M
Cap. Flow
+$23.6M
Cap. Flow %
5.61%
Top 10 Hldgs %
38.76%
Holding
222
New
25
Increased
56
Reduced
69
Closed
10

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$3.13M
2
FTGC icon
First Trust Global Tactical Commodity Strategy Fund
FTGC
+$1.36M
3
DBRG icon
DigitalBridge
DBRG
+$1.28M
4
FTCS icon
First Trust Capital Strength ETF
FTCS
+$1.12M
5
PLTR icon
Palantir
PLTR
+$1.09M

Top Sells

Rank Stock Value
1
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$628K
2
UBSI icon
United Bankshares
UBSI
+$499K
3
IHIT
Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share
IHIT
+$457K
4
XYZ
Block Inc
XYZ
+$429K
5
BX icon
Blackstone
BX
+$413K

Sector Composition

Rank Sector Weight
1 Technology 27.95%
2 Healthcare 18.49%
3 Financials 14.74%
4 Industrials 4.97%
5 Consumer Discretionary 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCF
201
DELISTED
Contango Oil & Gas Co.
MCF
$43K 0.01%
+10,000
New +$42K
STEX
202
Streamex Corp
STEX
$75.1M
$39K 0.01%
1,000
– –
ABUS icon
203
Arbutus Biopharma
ABUS
$915M
$37K 0.01%
+12,339
New +$38.2K
TEVA icon
204
Teva Pharmaceuticals
TEVA
$40.5B
$25K 0.01%
+2,550
New +$27K
VATE icon
205
INNOVATE Corp
VATE
$102M
$20K ﹤0.01%
+500
New +$20.2K
BCS icon
206
Barclays
BCS
$96.3B
$19K ﹤0.01%
1,960
+960
+96% +$9.81K
MAT icon
207
CALL
Mattel
MAT
$4.25B
$19K ﹤0.01%
150,000
-50,000
-25% -$1.03M
NVAX icon
208
CALL
Novavax
NVAX
$1.25B
$6K ﹤0.01%
1,000
– –
BCS icon
209
CALL
Barclays
BCS
$96.3B
$4K ﹤0.01%
29,000
+14,000
+93% +$143K
LYG icon
210
CALL
Lloyds Banking Group
LYG
$91.3B
$3K ﹤0.01%
+20,000
New +$51.4K
DIS icon
211
CALL
Walt Disney
DIS
$176B
$2K ﹤0.01%
+2,000
New +$360K
AKTS
212
CALL
DELISTED
Akoustis Technologies Inc
AKTS
$1K ﹤0.01%
+1,000
New +$10.6K
ARDX icon
213
Ardelyx
ARDX
$1.21B
– –
-10,204
Closed -$68K
BOC icon
214
Boston Omaha
BOC
$437M
– –
-10,460
Closed -$309K
KMX icon
215
CarMax
KMX
$8.07B
– –
-1,750
Closed -$232K
NSC icon
216
Norfolk Southern
NSC
$76.3B
– –
-860
Closed -$231K
OLED icon
217
CALL
Universal Display
OLED
$3.97B
– –
-5,000
Closed -$42K
SPLV icon
218
Invesco S&P 500 Low Volatility ETF
SPLV
$7.21B
– –
-4,575
Closed -$266K
UPS icon
219
CALL
United Parcel Service
UPS
$91.7B
– –
-1,000
Closed -$3K
ATRS
220
CALL
DELISTED
Antares Pharma, Inc.
ATRS
– –
-200,000
Closed -$18K
JHB
221
DELISTED
Nuveen Corporate Income November 2021 Target Term Fund
JHB
– –
-33,900
Closed -$318K
IHTA
222
DELISTED
Invesco High Income 2024 Target Term Fund
IHTA
– –
-21,705
Closed -$210K
5 6 7 8
9

Similar funds

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CFS
Cannon Financial Strategists Athens, Georgia $761M AUM 18.73% 1-Year Est. Return
TVAMP
Tennessee Valley Asset Management Partners Knoxville, Tennessee $757M AUM 14.19% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return
GWM
Gibbs Wealth Management Alpharetta, Georgia $762M AUM 18.55% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
JGUA
John G. Ullman & Associates Corning, New York $754M AUM 60.05% 1-Year Est. Return

Sargent Investment Group's Q2 2021 Portfolio in Review

As of Q2 2021, Sargent Investment Group held 222 positions worth $421M, up 11% from $380M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Sargent Investment Group deployed $23.6M of net new capital in Q2 2021, opening 25 new positions and adding to 56 existing holdings. Its largest new stake was Akoustis Technologies Inc: 32,965 shares worth $353K.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Avid Bioservices, Inc. Common Stock, an estimated $628K trimmed.

  • Sargent Investment Group's largest Q2 2021 buy was Akoustis Technologies Inc: 32,965 shares worth $353K.
  • Sargent Investment Group added most to IBM in Q2 2021, an estimated $3.13M increase.
  • Sargent Investment Group's biggest Q2 2021 reduction was Avid Bioservices, Inc. Common Stock, cutting an estimated $628K.
  • Sargent Investment Group fully exited Nuveen Corporate Income November 2021 Target Term Fund in Q2 2021, selling an estimated $318K.
  • Sargent Investment Group's ten largest holdings make up 39% of its $421M portfolio in Q2 2021.
  • Sargent Investment Group opened 25 new positions and closed 10 in Q2 2021.
  • Sargent Investment Group's portfolio value rose 11% quarter-over-quarter to $421M.

Based on Sargent Investment Group's 13F filing for Q2 2021, filed 5 Aug 2021.